Novartis Announces EU approval for Farydak
September 04, 2015 at 04:45 AM EDT
Novartis (NYSE: NVS) announced today that the European Commission has approved Farydak(R) (panobinostat, previously known as LBH589) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.